Pemazyre First FDA-Approved Therapy for Cholangiocarcinoma plus FGFR2 Fusion.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 34
- Publication type:
- Article
Works matching IS 21644403 AND DT 2020 AND VI 10 AND IP 6
Results: 13
1
2
Tabrecta First FDA-Approved Targeted Therapy for Metastatic NSCLC and MET Exon 14 Skipping.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 32
- Publication type:
- Article
3
Retevmo First Therapy Approved for 3 Types of Cancers with RET Mutations.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 32
- Publication type:
- Article
4
Oncology Biosimilars: 2020 Update.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 28
- By:
- Publication type:
- Article
5
Sitravatinib, Novel TKI, plus Nivolumab Elicits Good Responses in Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 26
- By:
- Publication type:
- Article
6
Drug Innovation to the Rescue: Profits from much-maligned Sovaldi helped Gilead's research.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 25
- Publication type:
- Article
7
Nivolumab-Based Chemotherapy Regimen Shows Activity in Muscle-Invasive Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 24
- By:
- Publication type:
- Article
8
I-SPY 2: Durvalumab plus Olaparib and Paclitaxel Triplet in High-Risk Breast Cancer "Graduates" to Phase 3 Study.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 22
- By:
- Publication type:
- Article
9
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 18
- By:
- Publication type:
- Article
10
Bispecific CAR T-Cells Show Promise in Children and Young Adults with Relapsed B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 16
- By:
- Publication type:
- Article
11
COVID-19: Challenges Facing Community Cancer Care Providers.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 1
- Publication type:
- Article
12
Universal CAR T-Cells a Promising Off-the-Shelf Therapy for T-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 1
- By:
- Publication type:
- Article
13
Will Home Infusion Become an Asset or a Battleground?
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 6, p. 1
- By:
- Publication type:
- Article